Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort study

[1]  G. Silecchia,et al.  Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD. , 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  G. Bedogni,et al.  Fatty liver, cardiometabolic disease and mortality. , 2019, Current opinion in lipidology.

[3]  A. Gastaldelli,et al.  Crosstalk between adipose tissue insulin resistance and liver macrophages in Non Alcoholic Fatty Liver Disease. , 2019, Journal of hepatology.

[4]  F. Tacke,et al.  Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD , 2019, Hepatology.

[5]  A. Iannelli,et al.  Liver transplantation for bariatric surgery-related liver failure: a systematic review of a rare condition. , 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[6]  Erfan Sheikhbahaei,et al.  Hepatic Failure After Bariatric Surgery: A Systematic Review , 2019, Hepatitis Monthly.

[7]  R. Othman,et al.  Lifestyle interventions for non-alcoholic fatty liver disease , 2019, Saudi journal of biological sciences.

[8]  S. Roberts,et al.  Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies , 2018, European journal of gastroenterology & hepatology.

[9]  Andrew A. Li,et al.  Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft , 2018, Journal of clinical and translational hepatology.

[10]  G. Colditz,et al.  Early major complications after bariatric surgery in the USA, 2003–2014: a systematic review and meta‐analysis , 2018, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[11]  M. Eslam,et al.  Genetics and epigenetics of NAFLD and NASH: Clinical impact. , 2018, Journal of hepatology.

[12]  M. A. Khan,et al.  Clinical epidemiology and disease burden of nonalcoholic fatty liver disease , 2017, World journal of gastroenterology.

[13]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[14]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[15]  Allison R. Schulman,et al.  Complications of Bariatric Surgery: What You Can Expect to See in Your GI Practice , 2017, The American Journal of Gastroenterology.

[16]  M. Trauner,et al.  Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal—a Case Series , 2017, Obesity Surgery.

[17]  C. Faselis,et al.  NAFLD-NASH: An Under-Recognized Epidemic. , 2017, Current vascular pharmacology.

[18]  S. Taylor-Robinson,et al.  Hepatic steatosis and fibrosis: Non-invasive assessment , 2016, World journal of gastroenterology.

[19]  Alan D. Lopez,et al.  Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet.

[20]  J. Pareja,et al.  Liver failure following biliopancreatic diversions: a narrative review , 2016, Sao Paulo medical journal = Revista paulista de medicina.

[21]  D. Kleiner,et al.  Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. , 2016, Metabolism: clinical and experimental.

[22]  D. Chirinos,et al.  Managing severe obesity: understanding and improving treatment adherence in bariatric surgery , 2016, Journal of Behavioral Medicine.

[23]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[24]  B. Wolfe,et al.  Treatment of Obesity: Weight Loss and Bariatric Surgery. , 2016, Circulation research.

[25]  C. Ricci,et al.  Rate of Death and Complications in Laparoscopic and Open Roux-en-Y Gastric Bypass. A Meta-analysis and Meta-regression Analysis on 69,494 Patients , 2016, Obesity Surgery.

[26]  G. Nguyen,et al.  Non-invasive diagnosis of advanced fibrosis and cirrhosis. , 2014, World journal of gastroenterology.

[27]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[28]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[29]  A. Lecube,et al.  Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. , 2012, World journal of hepatology.

[30]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[31]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[32]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[33]  C. Mottin,et al.  Effect of Bariatric Surgery on Liver Fibrosis , 2012, Obesity Surgery.

[34]  K. Hamdan,et al.  Management of late postoperative complications of bariatric surgery , 2011, The British journal of surgery.

[35]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[36]  E. Brunt.  Histopathology of non-alcoholic fatty liver disease. , 2009, Clinics in liver disease.

[37]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[38]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[39]  N. Jhala,et al.  Resolution of Nonalcoholic Steatohepatits after Gastric Bypass Surgery , 2007, Obesity surgery.

[40]  A. Halpern,et al.  Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years , 2007, Journal of gastroenterology and hepatology.

[41]  A. Lazenby,et al.  Influence of Liver Biopsy Heterogeneity and Diagnosis of Nonalcoholic Steatohepatitis in Subjects Undergoing Gastric Bypass , 2007, Obesity surgery.

[42]  Alyce Adams,et al.  Why is the Developed World Obese? , 2007, Annual review of public health.

[43]  A. Krasinskas,et al.  Surgically-Induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome , 2005, Annals of surgery.

[44]  S. Morini,et al.  Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[45]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[46]  C. Sjöström.  Surgery as an intervention for obesity. Results from the Swedish obese subjects study. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[47]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[48]  P. Giral,et al.  Liver fibrosis in overweight patients. , 2000, Gastroenterology.

[49]  W. Pories,et al.  Surgical intervention for the severely obese. , 1999, Bailliere's best practice & research. Clinical endocrinology & metabolism.

[50]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[51]  W. Pories,et al.  The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus , 1997, Journal of Gastrointestinal Surgery.

[52]  H. Appelman,et al.  Regression of hepatic steatosis in morbidly obese persons after gastric bypass. , 1995, American journal of clinical pathology.

[53]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: an expanded clinical entity. , 1994, Gastroenterology.

[54]  S. Auerbach,et al.  Impact of ethnicity , 1985 .

[55]  G. Marchesini,et al.  Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. , 2019, Transplantation.

[56]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[57]  H. Heneghan,et al.  Bariatric surgery for obesity , 2010 .

[58]  Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases , 2013 .

[59]  Brian P. Mulhall,et al.  Nonalcoholic steatohepatitis , 2004, Current treatment options in gastroenterology.

[60]  A. Reid.  Nonalcoholic steatohepatitis. , 2001, Gastroenterology.